Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status
2009 ◽
Vol 119
(1)
◽
pp. 53-61
◽
2001 ◽
Vol 65
(2)
◽
pp. 155-162
◽
2010 ◽
2006 ◽
Vol 98
(2)
◽
pp. 179-184
◽
Keyword(s):
2019 ◽
Vol 45
(5)
◽
pp. 877-878
2008 ◽
Vol 99
(8)
◽
pp. 1706-1707
◽